Diagnosis and Comorbidities

Diagnosis

The 2 most common types of IBD are Crohn’s disease (CD) and ulcerative colitis (UC), and both are distinguished by a dysregulated immune response. However, CD is typified by inflammation throughout the digestive tract, whereas UC is limited to the large intestine.1-4
Establishing a diagnosis of UC or CD involves a combination of several assessments that may include:
  • History and physical
  • Labs: both general and specific (TPMT, CRP)
  • Stool markers (fecal calprotectin)
  • Endoscopic evaluation
  • Imaging: CT, CTE, MRE, SBFT, rectal EUS, WCE
  • Risk stratification

Comorbidities

Compared with adults without IBD, those with IBD are more likely to have certain chronic health conditions, which include, but are not limited to:5-7

  • Acid-related disorders
  • Arthritis
  • Bone diseases
  • Cancer
  • Cardiovascular disease
  • Iron-deficiency anemia
  • Kidney disease
  • Liver disease
  • Pain
  • Psoriasis
  • Respiratory disease
  • Severe headache
  • Uveitis

Definitions: TPMT = thiopurine methyltransferase; CRP = C-reactive protein; CT = computed tomography (scan); CTE = computed tomography enterography; MRE = magnetic resonance enterography; SBFT = small-bowel follow-through; EUS = endoscopic ultrasound; WCE = wireless capsule endoscopy.

References

  1. Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501-523.
  2. Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn’s disease in adults. Am J Gastroenterol. 2009;104:465-483.
  3. Silverberg M, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A):5A-36A.
  4. McDowell C, Farooq U, Haseeb M. StatPearls [Internet]. Inflammatory bowel disease. May 1, 2022. https://www.ncbi.nlm.nih.gov/books/NBK470312/.
  5. Centers for Disease Control and Prevention. IBD comorbidities. https://www.cdc.gov/ibd/data-and-statistics/ comorbidities.html#:~:text=Compared%20with%20adults%20without%20IBD,and%20migraine%20or%20severe%20headache
  6. Argollo M, Gilardi D, Peyrin-Biroulet C, et al. Comorbidities in inflammatory bowel disease: a call for action. Lancet Gastroenterol Hepatol. 2019;4(8):643-654.
  7. Bähler C, Schoepfer A, Vavricka S, et al. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland. Eur J Gastroenterol Hepatol. 2017;29(8):916-925.
Scroll to Top